Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index; 7 of the 21 sources its claims cite were checked for support.
Abstract
Mdm2 directly regulates the p53 tumor suppressor. However, Mdm2 also has p53-independent activities, and the pathways that mediate these functions are unresolved. Here we report the identification of a specific association of Mdm2 with Mre11, Nbs1, and Rad50, a DNA double strand break repair complex. Mdm2 bound to the Mre11-Nbs1-Rad50 complex in primary cells and in cells containing inactivated p53 or p14/p19ARF, a regulator of Mdm2. Further analysis revealed that Mdm2 directly bound to Nbs1 but not to Mre11 or Rad50. Amino acids 198-314 of Mdm2 were required for Mdm2/Nbs1 association, and neither the N terminus forkhead-associated and breast cancer C-terminal domains nor the C terminus Mre11 binding domain of Nbs1 mediated the interaction of Nbs1 with Mdm2. Mdm2 co-localized with Nbs1 to sites of DNA damage following gamma-irradiation. Notably, Mdm2 overexpression inhibited DNA double strand break repair, and this was independent of p53 and ARF, the alternative reading frame of the Ink4alocus. The delay in DNA repair imposed by Mdm2 required the Nbs1 binding domain of Mdm2, but the ubiquitin ligase domain in Mdm2 was dispensable. Therefore, Nbs1 is a novel p53-independent Mdm2 binding protein and links Mdm2 to the Mre11-Nbs1-Rad50-regulated DNA repair response.
Overview
CoChat Summary
TL;DR
Mdm2 directly binds Nbs1, a component of the Mre11-Nbs1-Rad50 DNA double-strand break repair complex, independently of p53 and ARF. Mdm2 overexpression delays DNA double-strand break repair in a manner requiring the Nbs1-binding domain of Mdm2 but not its ubiquitin ligase domain.
Key findings
- Mdm2 co-immunoprecipitated with Mre11, Nbs1, and Rad50 in multiple cell types, including p53- or ARF-deficient cells, and this association did not require functional ATM or BRCA1.
- Mdm2 bound directly to Nbs1, but not to Mre11 or Rad50; Mdm2 amino acids 198–314 were required for M-N-R complex association, and the central region of Nbs1 (amino acids 221–540) mediated binding to Mdm2.
- Mdm2 co-localized with Nbs1 at nuclear foci after γ-irradiation in over 40% of cells where Nbs1 foci were detected, whereas p53 did not co-localize with Nbs1 at these sites.
- Mdm2 overexpression delayed DNA double-strand break repair independent of p53 and ARF; in p53−/− MEFs at 90 min post-irradiation, over 80% of Mdm2-overexpressing cells had tail moments >4 versus less than 50% of vector control cells. The delay required the Nbs1-binding domain but not the ubiquitin ligase domain.
Methods
- Endogenous Mdm2 was immunoprecipitated from HeLa and other cell lysates, followed by silver staining and mass spectrometry; co-immunoprecipitation and Western blotting were used across human and murine cell lines, primary IMR90 fibroblasts, p53−/− ARF−/− and p53−/− Mdm2−/− MEFs, and patient-derived NBS, ATLD, and A-T cells.
- Direct binding was tested with purified GST-Mdm2 and in vitro transcribed/translated [35S]Met-labeled p53, Nbs1, Mre11, and Bax, quantified by phosphorimaging.
- DNA damage localization was assessed by immunofluorescence in IMR90 and NBS fibroblasts after 12 Gy γ-irradiation; DNA repair was measured by neutral comet assay in NIH3T3 cells and p53−/− MEFs after 5 Gy γ-irradiation, with blinded computer scoring of at least 50 cells per interval per cell line.
Limitations
- The paper states that Mdm2 could not be detected in immunoprecipitations of endogenous Nbs1, Mre11, and Rad50, and that further analysis is required to define regulation of Mdm2 localization to nuclear foci, its release from these sites, and the role of Nbs1/Mdm2 interactions in these processes.
- The paper notes that Mdm2 did not co-localize with every Nbs1 focus and that early foci may be fainter and harder to detect, possibly underestimating Mdm2 localization at early foci.
- Evident from the text: many conclusions rely on overexpression systems and established cell lines, and the comet assay measures DNA double-strand breaks but does not establish the precise biochemical mechanism by which Mdm2 delays repair.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 5 Not checked · 60 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Combined, these reports suggest that Mdm2 has functions independent of p53 that contribute to transformation.”
§ Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [31] Jones, 1998, Proc. Natl. Acad. Sci. U. S. A. source
- Supportedcites [32] Lundgren, 1997, Genes Dev. source
The Discussion (page not supplied) says this study demonstrates an MDM2 role independent of p53 inhibition and implies a broader role in cellular transformation. The citing sentence is similarly hedged as a suggestion. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [33] Steinman, 2004, J. Biol. Chem. source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, Mdm2 also has p53-independent activities, and the pathways that mediate these functions are unresolved.”
- Also stated in: § Abstract · hedged
“In addition to p53-dependent functions, mounting evidence suggests Mdm2 also acts independent of p53.”
§ Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair* > Abstract
What the sources say
- Not checked — no full text of the sourcecites [31] Jones, 1998, Proc. Natl. Acad. Sci. U. S. A. source
- Supportedcites [32] Lundgren, 1997, Genes Dev. source
The Discussion states that this study demonstrates a role for MDM2 independent of p53 inhibition. It also says the mechanisms underlying the observed phenotype have not been defined. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [33] Steinman, 2004, J. Biol. Chem. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · hedged
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A forkhead-associated domain and a breast cancer C-terminal domain at the N terminus of Nbs1 are critical for proper nuclear localization of the M-N-R complex to nuclear foci or sites of DNA strand breaks (6).”
§ Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair* > Abstract
What the sources say
- Partly supportedcites [6] Desai-Mehta, 2001, Mol. Cell. Biol. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says amino-terminal sequences are required for radiation-induced focus formation and identifies the FHA and BRCT domains as candidates for that function, not as proven critical domains. It separately assigns nuclear localization to residues 401–652, so the claim conflates focus formation with nuclear localization and overstates the evidence for FHA and BRCT. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“To evaluate whether Mdm2 expression would influence Nbs1-mediated DNA repair, we took advantage of the comet assay, which under neutral conditions measures double strand breaks on a per cell basis (41,42).”
§ Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair* > Nbs1 Mediates the Interaction between
What the sources say
- Not matchedcites [41] Kobayashi, 1995, MMS Commun.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [42] Collins, 2004, Mol. Biotechnol. sourceExperimental — accuracy not yet measured
Section 2.2.2 describes a neutral comet-assay procedure designed to detect double-strand breaks, and the Conclusions describe the assay as measuring breaks in single cells. But Section 2.2.2 also says another neutral procedure detected single-strand breaks. Neutral conditions alone therefore do not establish that the assay measures double-strand breaks. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The association of Mdm2 with Nbs1 does not require Mre11, ATM, BRCA1, or p53, although all of these proteins are necessary for a normal cellular response to ionizing irradiation and to maintain DNA integrity (1,45).”
§ Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair* > DISCUSSION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
46 more claims
Create a free account to see all 71 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, in the context of DNA damage, MDM2 localizes to the nucleus and modulates DNA repair in a p53-independent manner by binding to and inactivating Nbs1 in the MRE11/Rad50/NBS1 complex.1,8,27”
From Combination therapy in a xenograft model of glioblastoma: Enhancement of the antitumor activity of temozolomide by an MDM2 antagonist (2017) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mdm2 can modulate the ability of cells to sense DNA damage through its direct binding to Nbs1 of the MRN DNA repair complex (24).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, we discovered the interaction between Mdm2 and Nbs1”
From Mdm2 Promotes Genetic Instability and Transformation Independent of p53 (2008) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Nbs1, a member of the Mre11/Rad50/Nbs1 complex that functions in DNA double-strand break repair and other functions that are necessary to maintain chromosomal stability (1, 54).”
From Mdm2 Promotes Genetic Instability and Transformation Independent of p53 (2008) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Further, Mdm2 and Nbs1 were found to co-localize together at sites of DNA damage after cells were treated with ionizing radiation to induce double-strand breaks [31].”
From Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis (2012) · cites this paper as [31]
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations
Collins, A. R. (2004) · Molecular Biotechnology · doi:10.1385/mb:26:3:249 · Cited by 2,892
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Genomic Instability in Mice Lacking Histone H2AX
Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002) · Science · doi:10.1126/science.1069398 · Cited by 1,385
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Self-citationCarney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome
Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H., Saar, K., Beckmann, G., Seemanová, E., Cooper, P. R., Nowak, N. J., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81174-5 · Cited by 1,079
Requirement of the MRN complex for ATM activation by DNA damage
Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., & Shiloh, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg541 · Cited by 1,075
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Choreography of the DNA Damage Response
Lisby, M., Barlow, J. H., Burgess, R. C., & Rothstein, R. (2004) · Cell · doi:10.1016/j.cell.2004.08.015 · Cited by 891
The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling
D'Amours, D., & Jackson, S. P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm805 · Cited by 874
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
Self-citationATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., & Kastan, M. B. (2000) · Nature · doi:10.1038/35007091 · Cited by 786
Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2004) · Science · doi:10.1126/science.1091496 · Cited by 762
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610
Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex
Paull, T. T., & Gellert, M. (1999) · Genes & Development · doi:10.1101/gad.13.10.1276 · Cited by 551
Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex
Stracker, T. H., Carson, C. T., & Weitzman, M. D. (2002) · Nature · doi:10.1038/nature00863 · Cited by 522
Iwakuma, T., & Lozano, G. (2003) · PubMed · Cited by 503
The Mre11 complex is required for ATM activation and the G2/M checkpoint
Carson, C. T., Schwartz, R. A., Stracker, T. H., Lilley, C. E., Lee, D. V., & Weitzman, M. D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg630 · Cited by 502
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products
Zhao, S., Weng, Y.-C., Yuan, S.-S. F., Lin, Y.-T., Hsu, H.-C., Lin, S.-C. J., Gerbino, E., Song, M.-H., Zdzienicka, M. Z., Gatti, R. A., et al. (2000) · Nature · doi:10.1038/35013083 · Cited by 483
ATM-dependent phosphorylation of nibrin in response to radiation exposure
Gatei, M., Young, D., Cerosaletti, K. M., Desai-Mehta, A., Spring, K., Kozlov, S., Lavin, M. F., Gatti, R. A., Concannon, P., & Khanna, K. (2000) · Nature Genetics · doi:10.1038/75508 · Cited by 468
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y., & Shkedy, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14973 · Cited by 461
DNA Damage-Dependent Nuclear Dynamics of the Mre11 Complex
Mirzoeva, O. K., & Petrini, J. H. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.281-288.2001 · Cited by 387
Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation
Stommel, J. M., & Wahl, G. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600145 · Cited by 386
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A., & Bradley, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15608 · Cited by 386
The cellular response to DNA double-strand breaks: defining the sensors and mediators
Petrini, J. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00170-3 · Cited by 339
NBS1 Localizes to γ-H2AX Foci through Interaction with the FHA/BRCT Domain
Kobayashi, J., Tauchi, H., Sakamoto, S., Nakamura, A., Morishima, K.-I., Matsuura, S., Kobayashi, T., Tamai, K., Tanimoto, K., & Komatsu, K. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01259-9 · Cited by 306
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
Tomlinson, G. E., Chen, T. T., Stastny, V., Virmani, A. K., Spillman, M. A., Tonk, V. S., Blum, J. L., Schneider, N. R., Wistuba, I. I., Shay, J. W., et al. (1998) · PubMed · Cited by 294
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., & Gellert, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111125998 · Cited by 282
Carroll, P. E., Okuda, M., Horn, H. F., Biddinger, P., Stambrook, P. J., Gleich, L. L., Li, Y.-Q., Tarapore, P., & Fukasawa, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202515 · Cited by 279
The International Nijmegen Breakage Syndrome Study Group (2000) · Archives of Disease in Childhood · doi:10.1136/adc.82.5.400 · Cited by 271
Mre11 Protein Complex Prevents Double-Strand Break Accumulation during Chromosomal DNA Replication
Costanzo, V., Robertson, K., Bibikova, M., Kim, E., Grieco, D., Gottesman, M., Carroll, D., & Gautier, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00294-5 · Cited by 239
Lundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P., & Finlay, C. A. (1997) · Genes & Development · doi:10.1101/gad.11.6.714 · Cited by 235
Dolganov, G. M., Maser, R. S., Novikov, A., Tosto, L., Chong, S., Bressan, D. A., & Petrini, J. H. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4832 · Cited by 224
Maser, R. S., Zinkel, R., & Petrini, J. H. J. (2001) · Nature Genetics · doi:10.1038/86920 · Cited by 216
Desai-Mehta, A., Cerosaletti, K. M., & Concannon, P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2184-2191.2001 · Cited by 196
Alani, E., Subbiah, S., & Kleckner, N. (1989) · Genetics · doi:10.1093/genetics/122.1.47 · Cited by 142
Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis
Alt, J. R., Greiner, T. C., Cleveland, J. L., & Eischen, C. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg133 · Cited by 129
Self-citationThe RING domain of Mdm2 can inhibit cell proliferation.
Dang, J., Kuo, M.-L., Eischen, C. M., Stepanova, L., Sherr, C. J., & Roussel, M. F. (2002) · PubMed · Cited by 99
Self-citationAn Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis
Steinman, H. A., Burstein, E., Lengner, C., Gosselin, J., Pihan, G., Duckett, C. S., & Jones, S. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305966200 · Cited by 96
Overexpression of the MDM2 Oncogene in Leukemia and Lymphoma
Watanabe, T., Ichikawa, A., Saito, H., & Hotta, T. (1996) · Leukemia & Lymphoma · doi:10.3109/10428199609093436 · Cited by 80
Wang, H., Yu, D., Agrawal, S., & Zhang, R. (2003) · The Prostate · doi:10.1002/pros.10187 · Cited by 78
Eischen, C. M., Alt, J. R., & Wang, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208052 · Cited by 34
Self-citationStimulation of human DNA polymerase epsilon by MDM2
Asahara, H. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg342 · Cited by 33
Mdm2 Regulates p53 Independently of p19ARF in Homeostatic Tissues
O'Leary, K. A., Mendrysa, S. M., Vaccaro, A., & Perry, M. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.186-191.2004 · Cited by 25
Research works printed but not linked: 4
- Dang, 2002, Cancer Res., 62, 1222
- Kobayashi, 1995, MMS Commun., 103
- Tomlinson, 1998, Cancer Res., 58, 3237
- Iwakuma, 2003, Mol. Cancer Res., 1, 993
Cited by
The MDM2-p53 pathway revisited
Subhasree, N., Jiangjiang, Q., Kalkunte, S., Minghai, W., & Ruiwen, Z. (2013) · The Journal of Biomedical Research · doi:10.7555/jbr.27.20130030 · Cited by 414
Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
Li, Q., & Lozano, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0053 · Cited by 190
Eischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161
Self-citationTargeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Nag, S., Zhang, X., Srivenugopal, K. S., Wang, M.-H., Wang, W., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113206660325 · Cited by 149
Xu, X., Xiong, X., & Sun, Y. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0018-0 · Cited by 164
Metadata
- Authors
- Alt, J. R., Bouska, A., Fernandez, M. R., Cerny, R. L., Xiao, H., & Eischen, C. M.
- Affiliations
- University of Nebraska Medical Center (US)
- University of Nebraska–Lincoln (US)
- Corresponding author
- Eischen, Christine M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 280
- Issue
- 19
- Pages
- 18771-18781
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2085875005
- Cited by
- 131
- References
- 58
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 9 · 2014: 8 · 2013: 6 · 2012: 9
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5630 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RR15635)
- National Cancer Institute (CA-09476, CA-09139, T32CA009139, P30CA036727, T32CA009476)
- National Center for Research Resources (P20RR015635)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- MDM2, NBS1, MRE11, RAD50, DNA double-strand break repair, DNA damage response, p53-independent function, gamma irradiation, forkhead-associated domain
- MeSH terms
- MRE11 Homologue Protein, Amino Acid Sequence, Animals, Cell Line, DNA Damage, DNA Repair, DNA-Binding Proteins, Gamma Rays, Glutathione Transferase, HeLa Cells, Humans, Mice, Transgenic, Microscopy, Fluorescence, Molecular Sequence Data, Mutation, Nuclear Proteins, Protein Binding, Proto-Oncogene Proteins, Time Factors, Blotting, Western, Tumor Suppressor Protein p53, Silver Staining, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Acid Anhydride Hydrolases, DNA, Complementary, Cell Cycle Proteins, K562 Cells, NIH 3T3 Cells, DNA Repair Enzymes, Cell Line, Tumor, Immunoprecipitation, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.